With the eyes of the world focused on the development of COVID-19 vaccines to address the devastating health and economic consequences of this truly global pandemic, the news that clinical trials of one of the candidate vaccines had been halted may have caused hearts to sink.
In reality, it underlined the priority commitment to the safety of everyone involved in fighting the coronavirus.
The COVID-19 crisis has underlined the importance of Europe’s health research eco-system, our resilience to health threats,... Read more
19 Conversations | The EFPIA podcast series
World Patient Safety Day
Will COVID-19 vaccines be safe?
Across the World, pharmaceutical companies and regulatory agencies are joining forces to find a safe and effective COVID-19...
Read more
The current open call will run from September 15 to October 13 2020
Read more
About the EFPIA newsletter
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.